ArticlePharmaceutics2022

Smad7 Antisense Oligonucleotide in Crohn's Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials.

Giovanni Monteleone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.